Flexible Solutions International Inc
FSI NYSE Miscellaneous Chemical Products Financials FY2016βFY2025
What Flexible Solutions International Inc does
No business description yet.
- Legal name
- FLEXIBLE SOLUTIONS INTERNATIONAL INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Apr 15, 2026
- Accession Β· CIK
- 0001493152-26-016796
0001069394
Revenue and margins
Flexible Solutions International Inc had $38.5M of revenue in fiscal 2025, up 0.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β9.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$0.6M in fiscal 2025, β1.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Flexible Solutions International Inc returned $1.3M to shareholders in fiscal 2025. The diluted share count rose 7.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Flexible Solutions International Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $6.7M | $6.8M | $7.7M | $10.0M | $6.6M |
| Debt incl. finance leases | $2.4M | $6.2M | $8.1M | $8.8M | $4.4M |
| Net debt / EBITDA | β0.7x | β0.1x | 0.1x | β0.2x | β0.3x |
| Debt / equity | 0.1x | 0.2x | 0.2x | 0.2x | 0.1x |
| Interest coverage | 27.4x | 24.1x | 7.0x | β | β |
| Current ratio | 2.4x | 3.0x | 3.0x | 2.9x | 3.1x |
| Quick ratio | 1.5x | 1.6x | 1.9x | 2.0x | 2.1x |
| Total assets | $39.6M | $51.6M | $55.5M | $60.0M | $61.8M |
| Total liabilities | $11.8M | $16.3M | $17.2M | $18.6M | $19.0M |
| Shareholders' equity | $25.1M | $32.6M | $35.2M | $38.0M | $38.9M |
| Net debt (β = net cash) | β$4.4M | β$0.7M | $0.4M | β$1.3M | β$2.2M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 1 / 9 | 5 / 9 | 6 / 9 | 7 / 9 | 6 / 9 | 3 / 9 | 6 / 9 | 5 / 9 |
| Accruals ratio | 0.1% | 4.3% | 19.3% | β1.4% | β8.1% | β2.9% | 12.2% | β6.2% | β4.4% | β4.9% |
| Altman Z'' | 9.04 | 10.30 | 5.30 | 4.39 | 5.34 | 6.21 | 6.65 | 6.02 | 6.33 | 6.02 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $16.2M | $15.5M | $17.8M | $27.4M | $31.4M | $34.4M | $45.8M | $38.3M | $38.2M | $38.5M |
| Gross profit | $7.0M | $6.0M | $5.6M | $8.6M | $9.8M | $11.4M | $13.9M | $10.4M | $13.2M | $12.5M |
| Research and development | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.2M | $0.3M | $0.6M |
| Operating income | $3.1M | $1.5M | $1.3M | $1.9M | $4.1M | $5.5M | $7.1M | $3.5M | $5.5M | $4.6M |
| Interest expense | $0.0M | $0.0M | $0.1M | $0.4M | $0.3M | $0.2M | $0.3M | $0.5M | β | β |
| Pretax income | $3.1M | $3.4M | $3.1M | $2.3M | $5.2M | $6.7M | $7.9M | $3.6M | $5.0M | $3.3M |
| Income tax | $1.0M | $0.7M | $0.5M | $0.0M | $1.6M | $2.4M | $0.1M | β$0.1M | $0.9M | $0.9M |
| Net income | $1.8M | $1.8M | $2.5M | $1.9M | $3.0M | $3.4M | $7.0M | $2.8M | $3.0M | $0.8M |
| Diluted EPS | $0.15 | $0.15 | $0.21 | $0.16 | $0.24 | $0.28 | $0.56 | $0.22 | $0.24 | $0.06 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $1.8M | $1.0M | β$2.2M | $2.4M | $5.7M | $4.5M | $1.5M | $6.1M | $5.6M | $3.8M |
| Capital expenditure | $0.1M | $0.4M | $0.2M | $1.8M | $1.1M | $0.8M | $2.0M | $5.0M | $5.0M | $4.4M |
| Free cash flow | $1.7M | $0.6M | β$2.4M | $0.5M | $4.6M | $3.8M | β$0.5M | $1.1M | $0.6M | β$0.6M |
| Depreciation and amortization | $0.5M | $0.3M | $0.3M | $0.6M | $0.9M | $1.0M | $1.3M | $1.7M | $2.0M | $2.0M |
| Stock-based compensation | $0.1M | $0.1M | $0.1M | $0.2M | $0.2M | $0.2M | $0.4M | $0.4M | $0.7M | $0.6M |
| Acquisitions | β | β | β | β | β$0.0M | β | $0.5M | β | β | β |
| Share buybacks | $1.6M | β | β | β | β | β | β | β | β | β |
| Dividends paid | β | β | β | $2.4M | β | β | β | $0.6M | $1.3M | $1.3M |
| Dividends and buybacks | $1.6M | β | β | $2.4M | β | β | β | $0.6M | $1.3M | $1.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.5M | $6.9M | $7.9M | $3.6M | $4.5M | $6.7M | $6.8M | $7.7M | $10.0M | $6.6M |
| Total debt | $1.1M | $0.4M | $4.4M | $4.4M | $3.8M | $2.4M | $6.2M | $8.1M | $8.8M | $4.4M |
| Deposits | β | β | β | β | β | β | $0.7M | β | β | β |
| Current assets | $9.5M | $14.0M | $21.2M | $17.5M | $19.0M | $23.8M | $31.0M | $30.2M | $34.6M | $32.9M |
| Current liabilities | $2.3M | $2.7M | $6.1M | $6.8M | $7.9M | $9.8M | $10.3M | $10.1M | $11.9M | $10.8M |
| Inventory | $3.8M | $4.7M | $8.7M | $9.2M | $8.4M | $9.5M | $14.4M | $11.1M | $10.9M | $10.5M |
| Property and equipment, net | $3.4M | $1.9M | $2.6M | $4.0M | $5.1M | $4.9M | $9.7M | $13.2M | $17.1M | $16.1M |
| Goodwill | β | β | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M |
| Intangible assets | $0.1M | $0.1M | $3.1M | $3.0M | $2.8M | $2.6M | $2.4M | $2.3M | $2.1M | $2.0M |
| Total assets | $15.2M | $17.8M | $31.2M | $32.4M | $35.1M | $39.6M | $51.6M | $55.5M | $60.0M | $61.8M |
| Total liabilities | $2.7M | $2.9M | $11.7M | $11.9M | $11.3M | $11.8M | $16.3M | $17.2M | $18.6M | $19.0M |
| Shareholders' equity | $12.5M | $14.9M | $17.1M | $17.9M | $21.2M | $25.1M | $32.6M | $35.2M | $38.0M | $38.9M |
| Margins | ||||||||||
| Gross margin | 43.0% | 38.6% | 31.6% | 31.4% | 31.1% | 33.1% | 30.3% | 27.2% | 34.6% | 32.6% |
| Operating margin | 19.0% | 9.8% | 7.3% | 7.0% | 13.1% | 15.9% | 15.4% | 9.1% | 14.4% | 11.9% |
| EBITDA margin | 22.2% | 11.5% | 9.3% | 9.2% | 15.8% | 18.7% | 18.2% | 13.5% | 19.5% | 17.0% |
| Net margin | 11.0% | 11.3% | 14.0% | 7.0% | 9.5% | 10.0% | 15.3% | 7.2% | 7.9% | 2.0% |
| FCF margin | 10.2% | 4.0% | β13.5% | 2.0% | 14.7% | 10.9% | β1.1% | 2.9% | 1.6% | β1.5% |
| Returns | ||||||||||
| Return on capital | 18.9% | 14.5% | 8.0% | 10.1% | 13.8% | 17.2% | 21.6% | 9.8% | 12.4% | 9.1% |
| Return on capital employed | 24.1% | 10.0% | 5.2% | 7.5% | 15.1% | 18.4% | 17.1% | 7.7% | 11.5% | 9.0% |
| Return on equity | 14.4% | 12.8% | 15.6% | 10.9% | 15.2% | 14.9% | 24.3% | 8.2% | 8.3% | 2.0% |
| Return on assets | 11.8% | 10.7% | 10.2% | 6.0% | 8.8% | 9.2% | 15.4% | 5.2% | 5.3% | 1.3% |
| Return on tangible equity | 14.5% | 11.8% | 21.9% | 15.4% | 18.7% | 17.3% | 25.4% | 9.1% | 9.1% | 2.3% |
| Growth | ||||||||||
| Revenue growth | β | β4.6% | 15.1% | 53.9% | 14.5% | 9.6% | 33.2% | β16.4% | β0.2% | 0.7% |
| Net income growth | β | β2.2% | 41.9% | β23.2% | 55.7% | 15.9% | 103.6% | β60.5% | 9.5% | β74.1% |
| EPS growth | β | 0.0% | 40.0% | β23.8% | 50.0% | 16.7% | 100.0% | β60.7% | 9.1% | β75.0% |
| FCF growth | β | β62.9% | β491.5% | β | 758.5% | β18.8% | β113.4% | β | β46.4% | β198.0% |
| Share count change | β | 0.8% | 0.8% | 2.3% | 1.8% | 1.6% | β0.3% | 0.2% | 1.5% | 7.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.4x | β3.7x | β2.1x | 0.3x | β0.1x | β0.7x | β0.1x | 0.1x | β0.2x | β0.3x |
| Debt / equity | 0.1x | 0.0x | 0.3x | 0.2x | 0.2x | 0.1x | 0.2x | 0.2x | 0.2x | 0.1x |
| Interest coverage | 74.0x | 34.3x | 13.9x | 4.5x | 15.8x | 27.4x | 24.1x | 7.0x | β | β |
| Current ratio | 4.1x | 5.2x | 3.5x | 2.6x | 2.4x | 2.4x | 3.0x | 3.0x | 2.9x | 3.1x |
| Quick ratio | 2.4x | 3.4x | 2.0x | 1.2x | 1.4x | 1.5x | 1.6x | 1.9x | 2.0x | 2.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.7% | 2.8% | 1.0% | 6.7% | 3.4% | 2.3% | 4.3% | 13.0% | 13.0% | 11.4% |
| Stock comp / revenue | 0.4% | 0.7% | 0.6% | 0.9% | 0.5% | 0.6% | 0.9% | 1.0% | 1.8% | 1.4% |
| Payouts / FCF | 94.8% | β | β | 445.2% | β | β | β | 55.7% | 207.9% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 1.0 | 5.0 | 6.0 | 7.0 | 6.0 | 3.0 | 6.0 | 5.0 |
| Altman Z'' | 9.0 | 10.3 | 5.3 | 4.4 | 5.3 | 6.2 | 6.7 | 6.0 | 6.3 | 6.0 |
| Accruals ratio | 0.1% | 4.3% | 19.3% | β1.4% | β8.1% | β2.9% | 12.2% | β6.2% | β4.4% | β4.9% |
Source: SEC EDGAR XBRL filings (CIK 0001069394). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.